(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 30.89% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.32%.
Personalis's revenue in 2026 is $69,648,000.On average, 9 Wall Street analysts forecast PSNL's revenue for 2026 to be $8,414,596,561, with the lowest PSNL revenue forecast at $7,998,057,238, and the highest PSNL revenue forecast at $8,756,114,861. On average, 9 Wall Street analysts forecast PSNL's revenue for 2027 to be $11,716,672,547, with the lowest PSNL revenue forecast at $10,192,396,019, and the highest PSNL revenue forecast at $12,843,557,378.
In 2028, PSNL is forecast to generate $16,934,662,009 in revenue, with the lowest revenue forecast at $14,949,796,156 and the highest revenue forecast at $18,847,331,898.